Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.37 |
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SCN4A | P35499 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13728121 | 0.95 | ADRB2 (0.36) | PRCPTLR2ADRB2ADRB1ADRB3 | |
| SCHEMBL10363588 | 0.88 | RAB9A (0.39) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL3714016 | 0.88 | RAB9A (0.39) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL8840314 | 0.84 | PRCP (0.39) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL24586238 | 0.83 | DPP4 (0.36) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL5539757 | 0.83 | RAB9A (0.38) | PRCPTLR2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11253690 | 0.83 | TLR2 (0.36) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL25397085 | 0.82 | ADRB2 (0.36) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL1263537 | 0.81 | TLR2 (0.35) | PRCPTLR2DPP7DPP4DPP8 | |
| SCHEMBL24587253 | 0.80 | TLR2 (0.40) | PRCPTLR2DPP7DPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246228-A1 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | HOFFMANN-LA ROCHE INC. (US) | 2021-08-12 | — | — | US | disclosed |
| EP-3842453-A1 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | F. Hoffmann-La Roche AG (CH) | 2021-06-30 | — | — | EP | disclosed |
| US-10899846-B2 | Fc-region variants with modified FcRn- and protein A-binding properties | HOFFMANN-LA ROCHE INC. (US) | 2021-01-26 | — | — | US | disclosed |
| EP-3215524-B1 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | HOFFMANN LA ROCHE (CH) | 2021-01-13 | — | — | EP | disclosed |
| US-20170342168-A1 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | HOFFMANN-LA ROCHE INC. (US) | 2017-11-30 | — | — | US | disclosed |
| EP-3215524-A1 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | F. Hoffmann-La Roche AG (CH) | 2017-09-13 | — | — | EP | disclosed |
| WO-2016071377-A1 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | F. HOFFMANN-LA ROCHE AG (CH) | 2016-05-12 | — | — | WO | disclosed |
| CN-1240479-A | Truncated soluble tumor necrosis factor type-I and type-II receptors | AMGEN INC (US) | 2000-01-05 | — | — | CN | disclosed |